Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (33)

2024

  1. Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Vol. 30, Núm. 2, pp. 223-230

2023

  1. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

    eClinicalMedicine, Vol. 57

2022

  1. Association between Hemagglutination Inhibition Antibody Titers and Protection Against Reverse-Transcription Polymerase Chain Reaction-Confirmed Influenza Illness in Children 6-35 Months of Age: Statistical Evaluation of a Correlate of Protection

    Open Forum Infectious Diseases, Vol. 9, Núm. 2

  2. Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 1

2021

  1. A novel class of fast-acting antimalarial agents: Substituted 15-membered azalides

    British Journal of Pharmacology, Vol. 178, Núm. 2, pp. 363-377

2020

  1. Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial

    The Pediatric infectious disease journal, Vol. 39, Núm. 1, pp. e1-e10

2019

  1. Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine

    The Pediatric infectious disease journal, Vol. 38, Núm. 8, pp. 866-872

2018

  1. Factors influencing access of pregnant women and their infants to their local healthcare system: A prospective, multi-centre, observational study

    BMC Pregnancy and Childbirth, Vol. 18, Núm. 1

  2. Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study

    Vaccine, Vol. 36, Núm. 31, pp. 4750-4758

  3. Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons

    The Lancet Child and Adolescent Health, Vol. 2, Núm. 5, pp. 338-349

2017

  1. European Respiratory Society guidelines for the management of adult bronchiectasis

    European Respiratory Journal, Vol. 50, Núm. 3

  2. Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 7, pp. 1505-1515

2013

  1. A multi-country study of intussusception in children under 2 years of age in Latin America: Analysis of prospective surveillance data

    BMC Gastroenterology, Vol. 13, Núm. 1

2012

  1. Design, synthesis, and in vitro activity of novel 2′- O -substituted 15-membered azalides

    Journal of Medicinal Chemistry, Vol. 55, Núm. 7, pp. 3216-3227

  2. Novel hybrid molecules based on 15-membered azalide as potential antimalarial agents

    European Journal of Medicinal Chemistry, Vol. 49, pp. 365-378

2011

  1. Four year immunogenicity of the RTS,S/AS02 A malaria vaccine in Mozambican children during a phase IIb trial

    Vaccine, Vol. 29, Núm. 35, pp. 6059-6067

  2. Horizontal transmission of a human rotavirus vaccine strain-A randomized, placebo-controlled study in twins

    Vaccine, Vol. 29, Núm. 51, pp. 9508-9513

  3. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in latin america

    Pediatric Infectious Disease Journal, Vol. 30, Núm. 6

2009

  1. A global benchmark study using affinity-based biosensors

    Analytical Biochemistry, Vol. 386, Núm. 2, pp. 194-216

2008

  1. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

    The Lancet, Vol. 371, Núm. 9619, pp. 1181-1189